Trusted Sources

MEGACE Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

MEGACE Safety Reports

Total MEGACE reports: 123. MEGACE FDA safety alerts: No. Reported deaths: 103    Reported hospitalizations: 20. Read More Here.

< Previous  Showing 101-123 of 123

Consumer or non-health professional from UNITED STATES reported MEGACE problem on July 25, 2006. Female patient, 76 years of age, weighting 99.21 lb, was diagnosed with decreased appetite, breast cancer and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, hallucination. MEGACE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ADRIAMYCIN PFS, DOCETAXEL, HERCEPTIN, LOPRESSOR, LIPITOR, WARFARIN, LANOXIN. Patient recovered.

MEGACE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2006. Female patient, 51 years of age, was diagnosed with decreased appetite and was treated with MEGACE. MEGACE dosage: unknown. During the same period patient was treated with DURAGESIC, OXYCONTIN, ARANESP, MAGIC MOUTHWASH, DILAUDID, ABRAXANE, ZOMETA. Patient died.

Health Professional from UNITED STATES reported MEGACE problem on Aug 29, 2006. Female patient, 73 years of age, was diagnosed with weight decreased and was treated with MEGACE. MEGACE dosage: unknown. Patient died on 04/17/2006.

MEGACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2005. Male patient, 70 years of age, weighting 200.6 lb, was diagnosed with hyperhidrosis, gastrooesophageal reflux disease and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperhidrosis. MEGACE dosage: unknown. During the same period patient was treated with PRILOSEC, GLUCOSAMINE, CHONDROITIN. Patient recovered.

Physician from UNITED STATES reported MEGACE problem on Oct 27, 2005. Female patient, 67 years of age, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. MEGACE dosage: unknown. Patient died on 10/08/2005.

MEGACE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 28, 2005. Female patient, 73 years of age, was diagnosed with increased appetite and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. MEGACE dosage: unknown. During the same period patient was treated with LASIX, EVISTA, ALPRAZOLAM, ATENOLOL, ACIPHEX, COMPAZINE, LEXAPRO, BENADRYL. Patient died on 10/23/2005.

Health Professional from UNITED STATES reported MEGACE problem on Oct 31, 2005. Female patient, 84 years of age, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. MEGACE dosage: unknown. Patient died on 10/30/2005.

MEGACE problem was reported by a Physician from UNITED STATES on May 22, 2006. Female patient, 90 years of age, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: pancreatic carcinoma. MEGACE dosage: unknown. Patient died on 03/24/2006.

Consumer or non-health professional from UNITED STATES reported MEGACE problem on June 29, 2006. Female patient, 89 years of age, was diagnosed with increased appetite and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state. MEGACE dosage: unknown. During the same period patient was treated with ENBREL, FOSAMAX, DETROL, NEXIUM, IRON PREPARATION, VITAMINS. Patient recovered.

MEGACE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient, 78 years of age, weighting 99.21 lb, was diagnosed with increased appetite and was treated with MEGACE. MEGACE dosage: unknown. During the same period patient was treated with PLAVIX. Patient died on 09/12/2006.

Consumer or non-health professional from UNITED STATES reported MEGACE problem on Dec 27, 2006. Male patient, 50 years of age, weighting 90.39 lb, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: hepatic neoplasm malignant, lung neoplasm malignant. MEGACE dosage: unknown. Patient died on 03/10/2006.

MEGACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 04, 2007. Male patient, 77 years of age, was treated with MEGACE. MEGACE dosage: unknown. Patient died.

Pharmacist from UNITED STATES reported MEGACE problem on Jan 26, 2007. Female patient, 61 years of age, was diagnosed with ovarian cancer and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. MEGACE dosage: unknown. Patient died on 12/16/2006.

MEGACE problem was reported by a Health Professional from UNITED STATES on Jan 31, 2007. Male patient, 77 years of age, was diagnosed with weight decreased and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression. MEGACE dosage: unknown. Patient died on 01/01/2007.

Health Professional from UNITED STATES reported MEGACE problem on Feb 01, 2007. Male patient, weighting 195.0 lb, was diagnosed with weight decreased and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: dehydration, pancytopenia. MEGACE dosage: 800 MG Q DAY. During the same period patient was treated with CISPLATIN, TAGAMET, PROCHLOPERAZINE MALEATE, ANZEMET, OMNICEF. Patient was hospitalized. Patient recovered.

MEGACE problem was reported by a Health Professional from UNITED STATES on Feb 15, 2007. Female patient, weighting 161.0 lb, was diagnosed with weight control and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: confusional state, pneumonia, sepsis. MEGACE dosage: 800 MG QDAY. During the same period patient was treated with COLACE, PERCOCET, OXYCODONE, PROCHOLPERAZINE MALEATE, KYTRIL, LEXARPO, ALPRZOLAM, LEVAQUIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MEGACE problem on Feb 12, 2007. Female patient, 65 years of age, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: brain neoplasm benign. MEGACE dosage: unknown. Patient recovered.

MEGACE problem was reported by a Health Professional from UNITED STATES on Feb 23, 2007. Female patient, weighting 151.0 lb, was diagnosed with weight decreased and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: confusional state, multi-organ failure, pneumonia, sepsis. MEGACE dosage: 800 MG QDAY. During the same period patient was treated with COLACE, PERCOCET, OXYCODONE, PROCHOLPERAZINE MALEATE, KYTRIL, LEXARPO, ALPRZOLAM, LEVAQUIN. Patient was hospitalized. Patient died on 02/09/2007.

Health Professional from UNITED STATES reported MEGACE problem on Oct 20, 2006. Female patient was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: oedema peripheral. MEGACE dosage: unknown. Patient recovered.

MEGACE problem was reported by a Pharmacist from UNITED STATES on Feb 23, 2007. Female patient, 83 years of age, weighting 134.3 lb, was diagnosed with increased appetite, oral intake reduced and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, creatinine renal clearance decreased, white blood cell count increased. MEGACE dosage: 625 MG QDAY PO. During the same period patient was treated with MEGACE ES, PROGESTERONE, IRON SUPPLEMENT, ATENOLOL. Patient was hospitalized. Patient died on 02/23/2007.

Consumer or non-health professional from UNITED STATES reported MEGACE problem on Mar 07, 2007. Female patient, 65 years of age, was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: brain neoplasm benign. MEGACE dosage: unknown. Patient recovered.

MEGACE problem was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient, 71 years of age, weighting 178.0 lb, was diagnosed with weight decreased and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, condition aggravated, dysphagia. MEGACE dosage: 20ML PO QD. During the same period patient was treated with FENTANYL, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported MEGACE problem on Mar 06, 2007. Female patient, 83 years of age, weighting 134.3 lb, was diagnosed with appetite disorder, oral intake reduced and was treated with MEGACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, condition aggravated, white blood cell count increased. MEGACE dosage: 625 MG QDAY PO. During the same period patient was treated with MEGACE ES, PROGESTERONE, IRON SUPPLEMENT, ATENOLOL. Patient was hospitalized. Patient died on 02/23/2007.

< Previous  Showing 101-123 of 123